PubMed , World Journal of Gastroenterology , vol
Providers review your full medical profile before prescribing Instructions are provided with all medications Ongoing communication is available if questions arise Patients are encouraged to follow all guidance and seek in-person care when necessary
Protocol : BPC-157: 500 mcg/day (near injury or systemic) CJC-1295 w/ DAC: 2 mg twice per week Ipamorelin: 100200 mcg, 12x/day Duration: 68 weeks max Stacking Summary Potential Side Effects and Safety Profile of BPC-157 Compared to most performance-enhancing drugs, peptides, or even over-the-counter recovery aids, BPC-157 is remarkably well-tolerated
Rodent studies have shown a wide variety of beneficial therapeutic effects listed below
Adipocyte energy metabolism & lipogenesis suppression: In vivo models of diet-induced obesity where 5-Amino-1MQ reduces lipogenesis and methylation marker levels
This is where honesty matters more than marketing